|
DIMT1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.171200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.759200E-01 |
| Normal-vs-Stage2 |
7.527600E-01 |
| Normal-vs-Stage3 |
2.626800E-01 |
| Normal-vs-Stage4 |
6.351900E-02 |
| Stage1-vs-Stage2 |
6.049400E-01 |
| Stage1-vs-Stage3 |
1.578210E-01 |
| Stage1-vs-Stage4 |
1.073580E-01 |
| Stage2-vs-Stage3 |
5.218800E-01 |
| Stage2-vs-Stage4 |
2.414800E-01 |
| Stage3-vs-Stage4 |
5.114400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.294800E-01 |
| Normal-vs-AfricanAmerican |
5.397800E-01 |
| Normal-vs-Asian |
1.220380E-01 |
| Caucasian-vs-AfricanAmerican |
1.870600E-01 |
| Caucasian-vs-Asian |
1.760610E-01 |
| AfricanAmerican-vs-Asian |
4.546800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.777600E-01 |
| Normal-vs-Female |
4.518300E-02 |
| Male-vs-Female |
9.386400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.147400E-01 |
| Normal-vs-Extreme_Weight |
6.550000E-01 |
| Normal-vs-Obese |
6.005400E-01 |
| Normal-vs-Extreme_Obese |
9.449600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.738800E-01 |
| Normal_Weight-vs-Obese |
2.419400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.110400E-01 |
| Extreme_Weight-vs-Obese |
3.446400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.062000E-01 |
| Obese-vs-Extreme_Obese |
1.816000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.100200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.738000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.011600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.141200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.816420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.374200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.796000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.708400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.629010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.602200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.125200E-01 |
| Normal-VS-Type2 PRCC |
7.781400E-01 |
| Normal-VS-KIRP CIMP |
1.547800E-01 |
| Normal-VS-Unclassified PRCC |
1.473010E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.924800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.401430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.486300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.127200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.146600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.976600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.865600E-01 |
| Normal-vs-N1 |
3.199600E-02 |
| Normal-vs-N2 |
6.342200E-01 |
| N0-vs-N1 |
5.403800E-03 |
| N0-vs-N2 |
5.233800E-01 |
| N1-vs-N2 |
5.058800E-01 |
|
|
